文献速递消化系统肿瘤

胃癌中瘤内产IL17细胞浸润与抗肿瘤免疫背景及辅助化疗更好反应相关

Intratumoral IL17-producing cells infiltration correlate with antitumor immune contexture and improved response to adjuvant chemotherapy in gastric cancer.
PubMed 文献 · Ann Oncol · 2019-01-01

研究纳入TCGA队列(n=351)和中山医院队列(n=458),评估IL17A mRNA及IL17A+细胞浸润与总生存、辅助化疗反应及免疫背景的关系。结果显示IL17A+细胞浸润与IL17A mRNA表达正相关(Spearman's ρ=0.811;P<0.001),高表达与改善的总生存相关,TNM II/III期患者中瘤内高IL17A+细胞或瘤周低IL17A+细胞者更受益于辅助化疗,且与更多抗肿瘤免疫细胞浸润相关。

要点

  • IL17A+细胞浸润与IL17A mRNA表达正相关(Spearman's ρ=0.811;P<0.001)。
  • 高IL17A mRNA表达和瘤内高IL17A+细胞与改善的总生存相关,校正混杂因素后仍显著。
  • TNM II/III期患者中,瘤内高IL17A+细胞或瘤周低IL17A+细胞者从辅助化疗中获益更多。

核心结论

  • IL17A mRNA表达和瘤内IL17A+细胞浸润与抗肿瘤免疫背景相关。
  • IL17A+细胞浸润可作为总生存的独立预后生物标志物和辅助化疗更好反应的预测生物标志物。
  • 需进一步开展前瞻性验证。

研究设计与样本

  • 研究纳入两个患者队列:癌症基因组图谱队列(TCGA,n=351)和中山医院队列(ZSHC,n=458)。
  • TCGA和ZSHC分别用于mRNA相关分析和细胞浸润相关分析。
  • 另纳入一个独立队列(初步中山医院队列,PZSHC,n=21)以识别IL17A mRNA与IL17A+细胞浸润的相关性。

主要发现

  • IL17A+细胞浸润与IL17A mRNA表达正相关(Spearman's ρ=0.811;P<0.001)。
  • 高IL17A mRNA表达和瘤内高IL17A+细胞与改善的总生存相关,校正混杂因素后仍显著。
  • TNM II/III期患者中,瘤内IL17A+细胞较高或瘤周IL17A+细胞较低者从辅助化疗中获益更多。
  • IL17A mRNA表达升高和瘤内IL17A+细胞浸润增加与更多抗肿瘤肥大细胞和自然杀伤细胞浸润及更少促肿瘤M2巨噬细胞浸润相关。
  • 高IL17A mRNA表达代表Th17细胞特征和免疫反应过程,并与细胞毒性GZMA、GZMB、IFNG、PRF1和TNFSF11表达增加相关。

关键数值与推荐

  • IL17A+细胞浸润与IL17A mRNA表达的相关系数Spearman's ρ=0.811(P<0.001)。
  • 高IL17A mRNA表达和瘤内高IL17A+细胞与改善的总生存相关,校正混杂因素后仍显著。
  • TNM II/III期患者中,瘤内高IL17A+细胞或瘤周低IL17A+细胞者从辅助化疗中获益更多。

临床怎么用

  • 作者认为IL17A+细胞浸润可用作总生存的独立预后生物标志物和辅助化疗更好反应的预测生物标志物。
  • 作者指出需进一步开展前瞻性验证。

局限性

  • 需进一步开展前瞻性验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tumor IL17-producing (IL17A+) cells infiltration has different prognostic values among various cancers. The objective of this study was to assess the effect of IL17A+ cells in gastric cancer. PATIENTS AND METHODS: The study included two patient cohorts, the Cancer Genome Atlas cohort (TCGA, n = 351) and the Zhongshan Hospital cohort (ZSHC, n = 458). The TCGA and ZSHC were used for mRNA-related and cells infiltration-related analyses, respectively. The roles of IL17A mRNA and IL17A+ cells in overall survival (OS), response to adjuvant chemotherapy (ACT), and immune contexture were evaluated. Another independent cohort was included to identify the correlation between mRNA of IL17A and IL17A+ cells infiltration (the preliminary Zhongshan Hospital cohort, PZSHC, n = 21). RESULTS: The infiltration of IL17A+ cells was positively correlated with the expression of IL17A mRNA (Spearman's ρ = 0.811; P < 0.001). High IL17A mRNA expression and intratumoral IL17A+ cells were correlated with improved OS and remained to be significant after adjusted for confounders. Patients with TNM II/III disease whose tumor present higher intratumoral IL17A+ cells or lower peritumoral IL17A+ cells can benefit more from ACT. Elevated IL17A mRNA expression and increased intratumoral IL17A+ cells infiltration was associated with more antitumor mast cells and nature killer cells infiltration and less pro-tumor M2 macrophages infiltration. High IL17A mRNA expression represented a Th17 cells signature and immune response process and was correlated with increased cytotoxic GZMA, GZMB, IFNG, PRF1, and TNFSF11 expression. CONCLUSIONS: IL17A mRNA expression and intratumoral IL17A+ cells infiltration were correlated with antitumor immune contexture. IL17A+ cells infiltration could be used as an independent prognostic biomarker for OS and predictive biomarker for superior response to ACT, and further prospective validation needs to be conducted.

来源:Ann Oncol,查看原文。版权归原作者所有。

引用

  1. Wang JT, Li H, Zhang H, et al. Intratumoral IL17-producing cells infiltration correlate with antitumor immune contexture and improved response to adjuvant chemotherapy in gastric cancer. Ann Oncol. 2019. PMID: 30445581. doi:10.1093/annonc/mdy505

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。